nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIA4—cerebellar cortex—hypothyroidism	0.047	0.139	CbGeAlD
Topiramate—GRIK1—cerebellar cortex—hypothyroidism	0.0412	0.122	CbGeAlD
Topiramate—Heat intolerance—Dextrothyroxine—hypothyroidism	0.026	0.0624	CcSEcCtD
Topiramate—Heat intolerance—Levothyroxine—hypothyroidism	0.026	0.0624	CcSEcCtD
Topiramate—GRIA1—cerebellar cortex—hypothyroidism	0.0205	0.0607	CbGeAlD
Topiramate—Temperature intolerance—Dextrothyroxine—hypothyroidism	0.0198	0.0476	CcSEcCtD
Topiramate—Temperature intolerance—Levothyroxine—hypothyroidism	0.0198	0.0476	CcSEcCtD
Topiramate—Heat intolerance—Liotrix—hypothyroidism	0.0191	0.0459	CcSEcCtD
Topiramate—GRIA4—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0177	0.0717	CbGpPWpGaD
Topiramate—GRIA4—nerve—hypothyroidism	0.0172	0.0511	CbGeAlD
Topiramate—GRIK1—nerve—hypothyroidism	0.0151	0.0448	CbGeAlD
Topiramate—GRIK2—cerebellar cortex—hypothyroidism	0.0147	0.0435	CbGeAlD
Topiramate—Temperature intolerance—Liotrix—hypothyroidism	0.0146	0.035	CcSEcCtD
Topiramate—GRIA3—nerve—hypothyroidism	0.0141	0.0417	CbGeAlD
Topiramate—GRIA3—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0128	0.0521	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—NEFH—hypothyroidism	0.0119	0.0484	CbGpPWpGaD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—NEFM—hypothyroidism	0.0101	0.0412	CbGpPWpGaD
Topiramate—GRIA4—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00873	0.0354	CbGpPWpGaD
Topiramate—Pharyngeal oedema—Liotrix—hypothyroidism	0.00838	0.0201	CcSEcCtD
Topiramate—Hyperthyroidism—Levothyroxine—hypothyroidism	0.00824	0.0198	CcSEcCtD
Topiramate—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.00824	0.0198	CcSEcCtD
Topiramate—GRIA1—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00769	0.0312	CbGpPWpGaD
Topiramate—GRIA1—nerve—hypothyroidism	0.0075	0.0222	CbGeAlD
Topiramate—Muscle twitching—Liothyronine—hypothyroidism	0.00675	0.0162	CcSEcCtD
Topiramate—Clotting—Liotrix—hypothyroidism	0.0067	0.0161	CcSEcCtD
Topiramate—GRIA3—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00634	0.0258	CbGpPWpGaD
Topiramate—Hyperthyroidism—Liotrix—hypothyroidism	0.00606	0.0146	CcSEcCtD
Topiramate—GRIK5—heart—hypothyroidism	0.00591	0.0175	CbGeAlD
Topiramate—Phlebitis—Liothyronine—hypothyroidism	0.00559	0.0134	CcSEcCtD
Topiramate—GRIA3—adrenal cortex—hypothyroidism	0.00539	0.016	CbGeAlD
Topiramate—GRIK2—nerve—hypothyroidism	0.00538	0.016	CbGeAlD
Topiramate—GRIA2—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.00538	0.0218	CbGpPWpGaD
Topiramate—Swelling face—Liotrix—hypothyroidism	0.00503	0.0121	CcSEcCtD
Topiramate—GRIK4—testis—hypothyroidism	0.005	0.0148	CbGeAlD
Topiramate—GRIK5—pituitary gland—hypothyroidism	0.00493	0.0146	CbGeAlD
Topiramate—GRIK3—pituitary gland—hypothyroidism	0.00493	0.0146	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00482	0.0196	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00482	0.0196	CbGpPWpGaD
Topiramate—GRIK4—cerebellum—hypothyroidism	0.00461	0.0137	CbGeAlD
Topiramate—Epigastric discomfort—Liotrix—hypothyroidism	0.00455	0.0109	CcSEcCtD
Topiramate—Hypernatraemia—Liotrix—hypothyroidism	0.00455	0.0109	CcSEcCtD
Topiramate—GRIK3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00449	0.0182	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00449	0.0182	CbGpPWpGaD
Topiramate—GRIK5—adrenal gland—hypothyroidism	0.00441	0.0131	CbGeAlD
Topiramate—GRIK3—adrenal gland—hypothyroidism	0.00441	0.0131	CbGeAlD
Topiramate—Acidosis—Liotrix—hypothyroidism	0.00433	0.0104	CcSEcCtD
Topiramate—GRIK5—thyroid gland—hypothyroidism	0.00425	0.0126	CbGeAlD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00414	0.0168	CbGpPWpGaD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00414	0.0168	CbGpPWpGaD
Topiramate—CYP2C19—urine—hypothyroidism	0.00408	0.0121	CbGeAlD
Topiramate—Angina pectoris—Liothyronine—hypothyroidism	0.00405	0.00973	CcSEcCtD
Topiramate—GRIA1—Amyotrophic lateral sclerosis (ALS)—NEFL—hypothyroidism	0.00404	0.0164	CbGpPWpGaD
Topiramate—CA1—nerve—hypothyroidism	0.00399	0.0118	CbGeAlD
Topiramate—GRIK1—female gonad—hypothyroidism	0.0039	0.0116	CbGeAlD
Topiramate—GRIA3—adrenal gland—hypothyroidism	0.00389	0.0115	CbGeAlD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00384	0.0156	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00384	0.0156	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00381	0.0155	CbGpPWpGaD
Topiramate—GRIA1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.0038	0.0154	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—SLC5A7—hypothyroidism	0.0037	0.015	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—SLC5A7—hypothyroidism	0.0037	0.015	CbGpPWpGaD
Topiramate—GRIA4—cerebellum—hypothyroidism	0.00365	0.0108	CbGeAlD
Topiramate—GRIK3—testis—hypothyroidism	0.00365	0.0108	CbGeAlD
Topiramate—GRIK5—testis—hypothyroidism	0.00365	0.0108	CbGeAlD
Topiramate—GRIK1—Neuronal System—SLC5A7—hypothyroidism	0.00344	0.0139	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—SLC5A7—hypothyroidism	0.00344	0.0139	CbGpPWpGaD
Topiramate—GRIK5—cerebellum—hypothyroidism	0.00337	0.00998	CbGeAlD
Topiramate—GRIK3—cerebellum—hypothyroidism	0.00337	0.00998	CbGeAlD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00327	0.0133	CbGpPWpGaD
Topiramate—GRIA3—testis—hypothyroidism	0.00322	0.00955	CbGeAlD
Topiramate—GRIK1—cerebellum—hypothyroidism	0.0032	0.00948	CbGeAlD
Topiramate—CA4—nerve—hypothyroidism	0.00312	0.00924	CbGeAlD
Topiramate—GRIK5—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00311	0.0126	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00311	0.0126	CbGpPWpGaD
Topiramate—Coagulopathy—Liotrix—hypothyroidism	0.00308	0.00739	CcSEcCtD
Topiramate—GRIA3—liver—hypothyroidism	0.00304	0.00902	CbGeAlD
Topiramate—GRIA3—cerebellum—hypothyroidism	0.00297	0.00882	CbGeAlD
Topiramate—GRIA4—Neuronal System—SLC5A7—hypothyroidism	0.00292	0.0119	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00289	0.0117	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00289	0.0117	CbGpPWpGaD
Topiramate—Hyperkinesia—Levothyroxine—hypothyroidism	0.00284	0.00682	CcSEcCtD
Topiramate—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00284	0.00682	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00277	0.0112	CbGpPWpGaD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00268	0.0109	CbGpPWpGaD
Topiramate—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00266	0.0108	CbGpPWpGaD
Topiramate—Disorientation—Levothyroxine—hypothyroidism	0.00264	0.00635	CcSEcCtD
Topiramate—Disorientation—Dextrothyroxine—hypothyroidism	0.00264	0.00635	CcSEcCtD
Topiramate—Hypocalcaemia—Liotrix—hypothyroidism	0.00262	0.00628	CcSEcCtD
Topiramate—Oliguria—Liotrix—hypothyroidism	0.0026	0.00624	CcSEcCtD
Topiramate—CA5A—liver—hypothyroidism	0.00252	0.00748	CbGeAlD
Topiramate—Creatinine increased—Liotrix—hypothyroidism	0.00252	0.00604	CcSEcCtD
Topiramate—Increased appetite—Dextrothyroxine—hypothyroidism	0.00252	0.00604	CcSEcCtD
Topiramate—Increased appetite—Levothyroxine—hypothyroidism	0.00252	0.00604	CcSEcCtD
Topiramate—Hypertension—Liothyronine—hypothyroidism	0.0025	0.00601	CcSEcCtD
Topiramate—GRIA4—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00246	0.00998	CbGpPWpGaD
Topiramate—Muscle twitching—Liotrix—hypothyroidism	0.00244	0.00586	CcSEcCtD
Topiramate—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00242	0.00582	CcSEcCtD
Topiramate—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00242	0.00582	CcSEcCtD
Topiramate—CYP3A4—urine—hypothyroidism	0.00241	0.00716	CbGeAlD
Topiramate—GRIK4—Neuronal System—NEFL—hypothyroidism	0.00238	0.00967	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—NEFL—hypothyroidism	0.00238	0.00967	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00238	0.00964	CbGpPWpGaD
Topiramate—Affect lability—Dextrothyroxine—hypothyroidism	0.00233	0.00559	CcSEcCtD
Topiramate—Affect lability—Levothyroxine—hypothyroidism	0.00233	0.00559	CcSEcCtD
Topiramate—Tachycardia—Liothyronine—hypothyroidism	0.00231	0.00554	CcSEcCtD
Topiramate—Fluid retention—Liotrix—hypothyroidism	0.00227	0.00546	CcSEcCtD
Topiramate—Irritability—Levothyroxine—hypothyroidism	0.00226	0.00542	CcSEcCtD
Topiramate—Irritability—Dextrothyroxine—hypothyroidism	0.00226	0.00542	CcSEcCtD
Topiramate—Mood swings—Dextrothyroxine—hypothyroidism	0.00224	0.00538	CcSEcCtD
Topiramate—Mood swings—Levothyroxine—hypothyroidism	0.00224	0.00538	CcSEcCtD
Topiramate—GRIK3—Neuronal System—NEFL—hypothyroidism	0.00221	0.00899	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—NEFL—hypothyroidism	0.00221	0.00899	CbGpPWpGaD
Topiramate—Hypotension—Liothyronine—hypothyroidism	0.00221	0.00531	CcSEcCtD
Topiramate—Dehydration—Levothyroxine—hypothyroidism	0.0022	0.00528	CcSEcCtD
Topiramate—Dehydration—Dextrothyroxine—hypothyroidism	0.0022	0.00528	CcSEcCtD
Topiramate—GRIA3—Neuronal System—SLC5A7—hypothyroidism	0.00212	0.00862	CbGpPWpGaD
Topiramate—Hyperkinesia—Liotrix—hypothyroidism	0.00209	0.00502	CcSEcCtD
Topiramate—Muscular weakness—Levothyroxine—hypothyroidism	0.00208	0.00501	CcSEcCtD
Topiramate—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00208	0.00501	CcSEcCtD
Topiramate—Dysphagia—Dextrothyroxine—hypothyroidism	0.00204	0.00491	CcSEcCtD
Topiramate—Dysphagia—Levothyroxine—hypothyroidism	0.00204	0.00491	CcSEcCtD
Topiramate—Phlebitis—Liotrix—hypothyroidism	0.00202	0.00485	CcSEcCtD
Topiramate—GRIK2—heart—hypothyroidism	0.002	0.00593	CbGeAlD
Topiramate—Sweating increased—Levothyroxine—hypothyroidism	0.00199	0.00478	CcSEcCtD
Topiramate—Angina pectoris—Levothyroxine—hypothyroidism	0.00199	0.00478	CcSEcCtD
Topiramate—Sweating increased—Dextrothyroxine—hypothyroidism	0.00199	0.00478	CcSEcCtD
Topiramate—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00199	0.00478	CcSEcCtD
Topiramate—Disorientation—Liotrix—hypothyroidism	0.00194	0.00467	CcSEcCtD
Topiramate—GRIA4—Neuronal System—NEFL—hypothyroidism	0.00188	0.00764	CbGpPWpGaD
Topiramate—Body temperature increased—Liothyronine—hypothyroidism	0.00187	0.00449	CcSEcCtD
Topiramate—Increased appetite—Liotrix—hypothyroidism	0.00185	0.00444	CcSEcCtD
Topiramate—Weight decreased—Dextrothyroxine—hypothyroidism	0.00185	0.00444	CcSEcCtD
Topiramate—Weight decreased—Levothyroxine—hypothyroidism	0.00185	0.00444	CcSEcCtD
Topiramate—GRIA3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00179	0.00725	CbGpPWpGaD
Topiramate—Hypoglycaemia—Liotrix—hypothyroidism	0.00178	0.00428	CcSEcCtD
Topiramate—GRIA1—testis—hypothyroidism	0.00172	0.0051	CbGeAlD
Topiramate—Affect lability—Liotrix—hypothyroidism	0.00171	0.00411	CcSEcCtD
Topiramate—CA5B—heart—hypothyroidism	0.00168	0.00497	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00166	0.00674	CbGpPWpGaD
Topiramate—Irritability—Liotrix—hypothyroidism	0.00166	0.00399	CcSEcCtD
Topiramate—Mood swings—Liotrix—hypothyroidism	0.00165	0.00396	CcSEcCtD
Topiramate—CA7—cerebellum—hypothyroidism	0.00164	0.00486	CbGeAlD
Topiramate—Blood creatinine increased—Liotrix—hypothyroidism	0.00163	0.00391	CcSEcCtD
Topiramate—SCN5A—heart—hypothyroidism	0.00162	0.00481	CbGeAlD
Topiramate—Dehydration—Liotrix—hypothyroidism	0.00162	0.00388	CcSEcCtD
Topiramate—GRIA1—cerebellum—hypothyroidism	0.00159	0.00471	CbGeAlD
Topiramate—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00158	0.00643	CbGpPWpGaD
Topiramate—Hypokalaemia—Liotrix—hypothyroidism	0.00158	0.0038	CcSEcCtD
Topiramate—CA5B—cardiovascular system—hypothyroidism	0.00158	0.00469	CbGeAlD
Topiramate—CA9—testis—hypothyroidism	0.00156	0.00462	CbGeAlD
Topiramate—Muscular weakness—Liotrix—hypothyroidism	0.00153	0.00368	CcSEcCtD
Topiramate—SCN5A—cardiovascular system—hypothyroidism	0.00153	0.00454	CbGeAlD
Topiramate—GRIK2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00152	0.00616	CbGpPWpGaD
Topiramate—Flushing—Levothyroxine—hypothyroidism	0.00152	0.00364	CcSEcCtD
Topiramate—Flushing—Dextrothyroxine—hypothyroidism	0.00152	0.00364	CcSEcCtD
Topiramate—Abdominal distension—Liotrix—hypothyroidism	0.00151	0.00363	CcSEcCtD
Topiramate—Dysphagia—Liotrix—hypothyroidism	0.0015	0.00361	CcSEcCtD
Topiramate—CA1—heart—hypothyroidism	0.00148	0.00439	CbGeAlD
Topiramate—Angina pectoris—Liotrix—hypothyroidism	0.00146	0.00352	CcSEcCtD
Topiramate—Sweating increased—Liotrix—hypothyroidism	0.00146	0.00352	CcSEcCtD
Topiramate—Bronchitis—Liotrix—hypothyroidism	0.00144	0.00347	CcSEcCtD
Topiramate—Alopecia—Levothyroxine—hypothyroidism	0.00144	0.00347	CcSEcCtD
Topiramate—Alopecia—Dextrothyroxine—hypothyroidism	0.00144	0.00347	CcSEcCtD
Topiramate—CA9—cerebellum—hypothyroidism	0.00144	0.00427	CbGeAlD
Topiramate—CA5B—gonad—hypothyroidism	0.00143	0.00425	CbGeAlD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00142	0.00578	CbGpPWpGaD
Topiramate—Tension—Dextrothyroxine—hypothyroidism	0.0014	0.00335	CcSEcCtD
Topiramate—Tension—Levothyroxine—hypothyroidism	0.0014	0.00335	CcSEcCtD
Topiramate—CA1—cardiovascular system—hypothyroidism	0.0014	0.00414	CbGeAlD
Topiramate—Nervousness—Dextrothyroxine—hypothyroidism	0.00138	0.00332	CcSEcCtD
Topiramate—Nervousness—Levothyroxine—hypothyroidism	0.00138	0.00332	CcSEcCtD
Topiramate—GRIA3—Neuronal System—NEFL—hypothyroidism	0.00137	0.00555	CbGpPWpGaD
Topiramate—GRIA2—testis—hypothyroidism	0.00137	0.00405	CbGeAlD
Topiramate—Weight decreased—Liotrix—hypothyroidism	0.00136	0.00326	CcSEcCtD
Topiramate—Tremor—Dextrothyroxine—hypothyroidism	0.00133	0.0032	CcSEcCtD
Topiramate—Tremor—Levothyroxine—hypothyroidism	0.00133	0.0032	CcSEcCtD
Topiramate—Renal failure—Liotrix—hypothyroidism	0.00132	0.00316	CcSEcCtD
Topiramate—GABRG2—pituitary gland—hypothyroidism	0.00131	0.0039	CbGeAlD
Topiramate—Agitation—Levothyroxine—hypothyroidism	0.00131	0.00314	CcSEcCtD
Topiramate—Agitation—Dextrothyroxine—hypothyroidism	0.00131	0.00314	CcSEcCtD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.0013	0.00528	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—SLC5A7—hypothyroidism	0.00127	0.00516	CbGpPWpGaD
Topiramate—GRIA2—cerebellum—hypothyroidism	0.00126	0.00374	CbGeAlD
Topiramate—Palpitations—Dextrothyroxine—hypothyroidism	0.00126	0.00302	CcSEcCtD
Topiramate—Palpitations—Levothyroxine—hypothyroidism	0.00126	0.00302	CcSEcCtD
Topiramate—CA5B—adrenal gland—hypothyroidism	0.00125	0.00371	CbGeAlD
Topiramate—CA5B—blood—hypothyroidism	0.00125	0.00371	CbGeAlD
Topiramate—Convulsion—Levothyroxine—hypothyroidism	0.00123	0.00296	CcSEcCtD
Topiramate—Convulsion—Dextrothyroxine—hypothyroidism	0.00123	0.00296	CcSEcCtD
Topiramate—SCN5A—blood—hypothyroidism	0.00121	0.00359	CbGeAlD
Topiramate—Arthralgia—Levothyroxine—hypothyroidism	0.00121	0.00291	CcSEcCtD
Topiramate—Arthralgia—Dextrothyroxine—hypothyroidism	0.00121	0.00291	CcSEcCtD
Topiramate—Anxiety—Levothyroxine—hypothyroidism	0.00121	0.0029	CcSEcCtD
Topiramate—Anxiety—Dextrothyroxine—hypothyroidism	0.00121	0.0029	CcSEcCtD
Topiramate—CA5B—thyroid gland—hypothyroidism	0.00121	0.00358	CbGeAlD
Topiramate—Hypoaesthesia—Liotrix—hypothyroidism	0.0012	0.00287	CcSEcCtD
Topiramate—GRIA3—BDNF signaling pathway—VAV3—hypothyroidism	0.00118	0.00478	CbGpPWpGaD
Topiramate—Confusional state—Dextrothyroxine—hypothyroidism	0.00117	0.00281	CcSEcCtD
Topiramate—Confusional state—Levothyroxine—hypothyroidism	0.00117	0.00281	CcSEcCtD
Topiramate—GRIK2—Neuronal System—SLC5A7—hypothyroidism	0.00116	0.00472	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00116	0.00471	CbGpPWpGaD
Topiramate—CA4—heart—hypothyroidism	0.00116	0.00343	CbGeAlD
Topiramate—SCN1A—cerebellum—hypothyroidism	0.00115	0.00341	CbGeAlD
Topiramate—Shock—Levothyroxine—hypothyroidism	0.00114	0.00274	CcSEcCtD
Topiramate—Shock—Dextrothyroxine—hypothyroidism	0.00114	0.00274	CcSEcCtD
Topiramate—GRIK2—cerebellum—hypothyroidism	0.00114	0.00338	CbGeAlD
Topiramate—Tachycardia—Dextrothyroxine—hypothyroidism	0.00113	0.00272	CcSEcCtD
Topiramate—Tachycardia—Levothyroxine—hypothyroidism	0.00113	0.00272	CcSEcCtD
Topiramate—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00112	0.0027	CcSEcCtD
Topiramate—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00112	0.0027	CcSEcCtD
Topiramate—Flushing—Liotrix—hypothyroidism	0.00112	0.00268	CcSEcCtD
Topiramate—CA1—blood—hypothyroidism	0.0011	0.00327	CbGeAlD
Topiramate—CA4—cardiovascular system—hypothyroidism	0.00109	0.00324	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00107	0.00434	CbGpPWpGaD
Topiramate—Alopecia—Liotrix—hypothyroidism	0.00106	0.00255	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00106	0.00254	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00106	0.00254	CcSEcCtD
Topiramate—Insomnia—Dextrothyroxine—hypothyroidism	0.00105	0.00252	CcSEcCtD
Topiramate—Insomnia—Levothyroxine—hypothyroidism	0.00105	0.00252	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00104	0.00423	CbGpPWpGaD
Topiramate—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00104	0.00249	CcSEcCtD
Topiramate—Dyspnoea—Levothyroxine—hypothyroidism	0.00104	0.00249	CcSEcCtD
Topiramate—CA5B—testis—hypothyroidism	0.00103	0.00307	CbGeAlD
Topiramate—Flatulence—Liotrix—hypothyroidism	0.00103	0.00248	CcSEcCtD
Topiramate—Tension—Liotrix—hypothyroidism	0.00103	0.00247	CcSEcCtD
Topiramate—Dysgeusia—Liotrix—hypothyroidism	0.00103	0.00246	CcSEcCtD
Topiramate—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00102	0.00414	CbGpPWpGaD
Topiramate—Nervousness—Liotrix—hypothyroidism	0.00102	0.00244	CcSEcCtD
Topiramate—Fatigue—Dextrothyroxine—hypothyroidism	0.001	0.00241	CcSEcCtD
Topiramate—Fatigue—Levothyroxine—hypothyroidism	0.001	0.00241	CcSEcCtD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000995	0.00404	CbGpPWpGaD
Topiramate—CA2—adrenal cortex—hypothyroidism	0.000992	0.00294	CbGeAlD
Topiramate—Vision blurred—Liotrix—hypothyroidism	0.000987	0.00237	CcSEcCtD
Topiramate—Tremor—Liotrix—hypothyroidism	0.000981	0.00236	CcSEcCtD
Topiramate—GRIK2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000978	0.00397	CbGpPWpGaD
Topiramate—GABRB2—testis—hypothyroidism	0.000971	0.00288	CbGeAlD
Topiramate—CA4—pituitary gland—hypothyroidism	0.000966	0.00286	CbGeAlD
Topiramate—Agitation—Liotrix—hypothyroidism	0.000962	0.00231	CcSEcCtD
Topiramate—CA2—heart—hypothyroidism	0.000959	0.00284	CbGeAlD
Topiramate—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000957	0.0023	CcSEcCtD
Topiramate—Feeling abnormal—Levothyroxine—hypothyroidism	0.000957	0.0023	CcSEcCtD
Topiramate—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00095	0.00228	CcSEcCtD
Topiramate—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00095	0.00228	CcSEcCtD
Topiramate—Syncope—Liotrix—hypothyroidism	0.000939	0.00225	CcSEcCtD
Topiramate—Palpitations—Liotrix—hypothyroidism	0.000925	0.00222	CcSEcCtD
Topiramate—Urticaria—Levothyroxine—hypothyroidism	0.000923	0.00222	CcSEcCtD
Topiramate—Urticaria—Dextrothyroxine—hypothyroidism	0.000923	0.00222	CcSEcCtD
Topiramate—Loss of consciousness—Liotrix—hypothyroidism	0.00092	0.00221	CcSEcCtD
Topiramate—Abdominal pain—Levothyroxine—hypothyroidism	0.000918	0.00221	CcSEcCtD
Topiramate—Body temperature increased—Levothyroxine—hypothyroidism	0.000918	0.00221	CcSEcCtD
Topiramate—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000918	0.00221	CcSEcCtD
Topiramate—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000918	0.00221	CcSEcCtD
Topiramate—Convulsion—Liotrix—hypothyroidism	0.000907	0.00218	CcSEcCtD
Topiramate—CA2—cardiovascular system—hypothyroidism	0.000905	0.00268	CbGeAlD
Topiramate—Hypertension—Liotrix—hypothyroidism	0.000904	0.00217	CcSEcCtD
Topiramate—GABRG2—cerebellum—hypothyroidism	0.000897	0.00266	CbGeAlD
Topiramate—GABRB2—cerebellum—hypothyroidism	0.000897	0.00266	CbGeAlD
Topiramate—Arthralgia—Liotrix—hypothyroidism	0.000891	0.00214	CcSEcCtD
Topiramate—Chest pain—Liotrix—hypothyroidism	0.000891	0.00214	CcSEcCtD
Topiramate—GRIA2—Neuronal System—SLC5A7—hypothyroidism	0.00089	0.00361	CbGpPWpGaD
Topiramate—Anxiety—Liotrix—hypothyroidism	0.000888	0.00213	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000872	0.00354	CbGpPWpGaD
Topiramate—CA1—liver—hypothyroidism	0.000863	0.00256	CbGeAlD
Topiramate—CA4—adrenal gland—hypothyroidism	0.000863	0.00256	CbGeAlD
Topiramate—CA4—blood—hypothyroidism	0.000863	0.00256	CbGeAlD
Topiramate—Confusional state—Liotrix—hypothyroidism	0.000861	0.00207	CcSEcCtD
Topiramate—Oedema—Liotrix—hypothyroidism	0.000854	0.00205	CcSEcCtD
Topiramate—Infection—Liotrix—hypothyroidism	0.000849	0.00204	CcSEcCtD
Topiramate—Shock—Liotrix—hypothyroidism	0.000841	0.00202	CcSEcCtD
Topiramate—Tachycardia—Liotrix—hypothyroidism	0.000834	0.002	CcSEcCtD
Topiramate—Asthenia—Levothyroxine—hypothyroidism	0.000833	0.002	CcSEcCtD
Topiramate—Asthenia—Dextrothyroxine—hypothyroidism	0.000833	0.002	CcSEcCtD
Topiramate—CA4—thyroid gland—hypothyroidism	0.000833	0.00247	CbGeAlD
Topiramate—Hyperhidrosis—Liotrix—hypothyroidism	0.000826	0.00198	CcSEcCtD
Topiramate—Pruritus—Dextrothyroxine—hypothyroidism	0.000822	0.00197	CcSEcCtD
Topiramate—Pruritus—Levothyroxine—hypothyroidism	0.000822	0.00197	CcSEcCtD
Topiramate—GRIA1—Neuronal System—NEFL—hypothyroidism	0.00082	0.00333	CbGpPWpGaD
Topiramate—Anorexia—Liotrix—hypothyroidism	0.000814	0.00196	CcSEcCtD
Topiramate—CA4—female gonad—hypothyroidism	0.000805	0.00239	CbGeAlD
Topiramate—CA2—pituitary gland—hypothyroidism	0.000801	0.00238	CbGeAlD
Topiramate—Hypotension—Liotrix—hypothyroidism	0.000798	0.00192	CcSEcCtD
Topiramate—GABRG2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000798	0.00324	CbGpPWpGaD
Topiramate—Diarrhoea—Levothyroxine—hypothyroidism	0.000795	0.00191	CcSEcCtD
Topiramate—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000795	0.00191	CcSEcCtD
Topiramate—GABRA1—cerebellum—hypothyroidism	0.000792	0.00235	CbGeAlD
Topiramate—CYP2C19—blood—hypothyroidism	0.000781	0.00232	CbGeAlD
Topiramate—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000778	0.00187	CcSEcCtD
Topiramate—Insomnia—Liotrix—hypothyroidism	0.000773	0.00186	CcSEcCtD
Topiramate—Paraesthesia—Liotrix—hypothyroidism	0.000767	0.00184	CcSEcCtD
Topiramate—Dyspnoea—Liotrix—hypothyroidism	0.000762	0.00183	CcSEcCtD
Topiramate—GRIK2—Neuronal System—NEFL—hypothyroidism	0.00075	0.00304	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000748	0.00304	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000747	0.00303	CbGpPWpGaD
Topiramate—Decreased appetite—Liotrix—hypothyroidism	0.000743	0.00178	CcSEcCtD
Topiramate—Vomiting—Levothyroxine—hypothyroidism	0.000738	0.00177	CcSEcCtD
Topiramate—Vomiting—Dextrothyroxine—hypothyroidism	0.000738	0.00177	CcSEcCtD
Topiramate—Fatigue—Liotrix—hypothyroidism	0.000737	0.00177	CcSEcCtD
Topiramate—Rash—Dextrothyroxine—hypothyroidism	0.000732	0.00176	CcSEcCtD
Topiramate—Rash—Levothyroxine—hypothyroidism	0.000732	0.00176	CcSEcCtD
Topiramate—Dermatitis—Dextrothyroxine—hypothyroidism	0.000732	0.00176	CcSEcCtD
Topiramate—Dermatitis—Levothyroxine—hypothyroidism	0.000732	0.00176	CcSEcCtD
Topiramate—Constipation—Liotrix—hypothyroidism	0.000731	0.00175	CcSEcCtD
Topiramate—Headache—Levothyroxine—hypothyroidism	0.000728	0.00175	CcSEcCtD
Topiramate—Headache—Dextrothyroxine—hypothyroidism	0.000728	0.00175	CcSEcCtD
Topiramate—CA2—adrenal gland—hypothyroidism	0.000716	0.00212	CbGeAlD
Topiramate—CA2—blood—hypothyroidism	0.000716	0.00212	CbGeAlD
Topiramate—CA4—testis—hypothyroidism	0.000714	0.00212	CbGeAlD
Topiramate—SCN1A—Axon guidance—CLTC—hypothyroidism	0.000709	0.00288	CbGpPWpGaD
Topiramate—GRIA1—BDNF signaling pathway—VAV3—hypothyroidism	0.000705	0.00286	CbGpPWpGaD
Topiramate—Feeling abnormal—Liotrix—hypothyroidism	0.000704	0.00169	CcSEcCtD
Topiramate—Gastrointestinal pain—Liotrix—hypothyroidism	0.000699	0.00168	CcSEcCtD
Topiramate—GABRA1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000697	0.00283	CbGpPWpGaD
Topiramate—CA2—thyroid gland—hypothyroidism	0.000691	0.00205	CbGeAlD
Topiramate—Nausea—Dextrothyroxine—hypothyroidism	0.00069	0.00166	CcSEcCtD
Topiramate—Nausea—Levothyroxine—hypothyroidism	0.00069	0.00166	CcSEcCtD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000684	0.00278	CbGpPWpGaD
Topiramate—Urticaria—Liotrix—hypothyroidism	0.000679	0.00163	CcSEcCtD
Topiramate—Body temperature increased—Liotrix—hypothyroidism	0.000675	0.00162	CcSEcCtD
Topiramate—Abdominal pain—Liotrix—hypothyroidism	0.000675	0.00162	CcSEcCtD
Topiramate—GABRA1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000672	0.00273	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—SLC5A7—hypothyroidism	0.000668	0.00271	CbGpPWpGaD
Topiramate—CA2—female gonad—hypothyroidism	0.000667	0.00198	CbGeAlD
Topiramate—CA4—cerebellum—hypothyroidism	0.000659	0.00195	CbGeAlD
Topiramate—CA5A—Metabolism—IYD—hypothyroidism	0.000639	0.00259	CbGpPWpGaD
Topiramate—CA6—Metabolism—IYD—hypothyroidism	0.000639	0.00259	CbGpPWpGaD
Topiramate—Hypersensitivity—Liotrix—hypothyroidism	0.000629	0.00151	CcSEcCtD
Topiramate—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000616	0.0025	CbGpPWpGaD
Topiramate—Asthenia—Liotrix—hypothyroidism	0.000613	0.00147	CcSEcCtD
Topiramate—GABRG2—Neuronal System—SLC5A7—hypothyroidism	0.000611	0.00248	CbGpPWpGaD
Topiramate—CYP2C19—liver—hypothyroidism	0.000611	0.00181	CbGeAlD
Topiramate—Pruritus—Liotrix—hypothyroidism	0.000604	0.00145	CcSEcCtD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.000598	0.00243	CbGpPWpGaD
Topiramate—CA5B—Metabolism—IYD—hypothyroidism	0.000597	0.00242	CbGpPWpGaD
Topiramate—CA7—Metabolism—IYD—hypothyroidism	0.000597	0.00242	CbGpPWpGaD
Topiramate—CA2—testis—hypothyroidism	0.000592	0.00175	CbGeAlD
Topiramate—Diarrhoea—Liotrix—hypothyroidism	0.000585	0.0014	CcSEcCtD
Topiramate—GRIA2—Neuronal System—NEFL—hypothyroidism	0.000573	0.00233	CbGpPWpGaD
Topiramate—Dizziness—Liotrix—hypothyroidism	0.000565	0.00136	CcSEcCtD
Topiramate—GABRB2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000562	0.00228	CbGpPWpGaD
Topiramate—CA2—liver—hypothyroidism	0.00056	0.00166	CbGeAlD
Topiramate—CA12—Metabolism—IYD—hypothyroidism	0.000553	0.00224	CbGpPWpGaD
Topiramate—CA2—cerebellum—hypothyroidism	0.000547	0.00162	CbGeAlD
Topiramate—CA5A—Metabolism—ATP5O—hypothyroidism	0.000543	0.00221	CbGpPWpGaD
Topiramate—CA6—Metabolism—ATP5O—hypothyroidism	0.000543	0.00221	CbGpPWpGaD
Topiramate—Vomiting—Liotrix—hypothyroidism	0.000543	0.0013	CcSEcCtD
Topiramate—Rash—Liotrix—hypothyroidism	0.000539	0.00129	CcSEcCtD
Topiramate—Dermatitis—Liotrix—hypothyroidism	0.000538	0.00129	CcSEcCtD
Topiramate—Headache—Liotrix—hypothyroidism	0.000535	0.00129	CcSEcCtD
Topiramate—GABRA1—Neuronal System—SLC5A7—hypothyroidism	0.000534	0.00217	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000514	0.00209	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TPO—hypothyroidism	0.000511	0.00207	CbGpPWpGaD
Topiramate—CA6—Metabolism—TPO—hypothyroidism	0.000511	0.00207	CbGpPWpGaD
Topiramate—Nausea—Liotrix—hypothyroidism	0.000507	0.00122	CcSEcCtD
Topiramate—CA5B—Metabolism—ATP5O—hypothyroidism	0.000507	0.00206	CbGpPWpGaD
Topiramate—CA7—Metabolism—ATP5O—hypothyroidism	0.000507	0.00206	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—CLTC—hypothyroidism	0.000506	0.00205	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—CLTC—hypothyroidism	0.000499	0.00202	CbGpPWpGaD
Topiramate—GRIA2—BDNF signaling pathway—VAV3—hypothyroidism	0.000493	0.002	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TPO—hypothyroidism	0.000477	0.00194	CbGpPWpGaD
Topiramate—CA7—Metabolism—TPO—hypothyroidism	0.000477	0.00194	CbGpPWpGaD
Topiramate—CA12—Metabolism—ATP5O—hypothyroidism	0.00047	0.00191	CbGpPWpGaD
Topiramate—CYP3A4—blood—hypothyroidism	0.000462	0.00137	CbGeAlD
Topiramate—GABRA1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000449	0.00182	CbGpPWpGaD
Topiramate—CA12—Metabolism—TPO—hypothyroidism	0.000442	0.00179	CbGpPWpGaD
Topiramate—CA4—Metabolism—IYD—hypothyroidism	0.000441	0.00179	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—NEFL—hypothyroidism	0.000431	0.00175	CbGpPWpGaD
Topiramate—CA2—Metabolism—IYD—hypothyroidism	0.000423	0.00172	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000406	0.00165	CbGpPWpGaD
Topiramate—CA1—Metabolism—IYD—hypothyroidism	0.000405	0.00164	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—NEFL—hypothyroidism	0.000394	0.0016	CbGpPWpGaD
Topiramate—CA4—Metabolism—ATP5O—hypothyroidism	0.000375	0.00152	CbGpPWpGaD
Topiramate—CYP3A4—liver—hypothyroidism	0.000361	0.00107	CbGeAlD
Topiramate—CA2—Metabolism—ATP5O—hypothyroidism	0.000359	0.00146	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000359	0.00146	CbGpPWpGaD
Topiramate—CA9—Metabolism—IYD—hypothyroidism	0.000356	0.00145	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000356	0.00144	CbGpPWpGaD
Topiramate—CA4—Metabolism—TPO—hypothyroidism	0.000352	0.00143	CbGpPWpGaD
Topiramate—CA1—Metabolism—ATP5O—hypothyroidism	0.000345	0.0014	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—NEFL—hypothyroidism	0.000344	0.0014	CbGpPWpGaD
Topiramate—CA2—Metabolism—TPO—hypothyroidism	0.000338	0.00137	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—VAV3—hypothyroidism	0.000334	0.00136	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000329	0.00133	CbGpPWpGaD
Topiramate—CA1—Metabolism—TPO—hypothyroidism	0.000324	0.00131	CbGpPWpGaD
Topiramate—CA9—Metabolism—ATP5O—hypothyroidism	0.000303	0.00123	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000298	0.00121	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000287	0.00117	CbGpPWpGaD
Topiramate—CA9—Metabolism—TPO—hypothyroidism	0.000285	0.00116	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000272	0.00111	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000268	0.00109	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VAV3—hypothyroidism	0.000238	0.000968	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000238	0.000966	CbGpPWpGaD
Topiramate—CA6—Metabolism—TSHB—hypothyroidism	0.000237	0.00096	CbGpPWpGaD
Topiramate—CA5A—Metabolism—TSHB—hypothyroidism	0.000237	0.00096	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VAV3—hypothyroidism	0.000235	0.000954	CbGpPWpGaD
Topiramate—CA7—Metabolism—TSHB—hypothyroidism	0.000221	0.000896	CbGpPWpGaD
Topiramate—CA5B—Metabolism—TSHB—hypothyroidism	0.000221	0.000896	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3C2A—hypothyroidism	0.000211	0.000856	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3C2A—hypothyroidism	0.000211	0.000856	CbGpPWpGaD
Topiramate—CA12—Metabolism—TSHB—hypothyroidism	0.000205	0.00083	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3C2A—hypothyroidism	0.000197	0.000799	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3C2A—hypothyroidism	0.000197	0.000799	CbGpPWpGaD
Topiramate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000196	0.000797	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3C2A—hypothyroidism	0.000182	0.00074	CbGpPWpGaD
Topiramate—CA5A—Metabolism—SLC5A5—hypothyroidism	0.000177	0.000719	CbGpPWpGaD
Topiramate—CA6—Metabolism—SLC5A5—hypothyroidism	0.000177	0.000719	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000168	0.000681	CbGpPWpGaD
Topiramate—CA7—Metabolism—SLC5A5—hypothyroidism	0.000165	0.000671	CbGpPWpGaD
Topiramate—CA5B—Metabolism—SLC5A5—hypothyroidism	0.000165	0.000671	CbGpPWpGaD
Topiramate—CA4—Metabolism—TSHB—hypothyroidism	0.000163	0.000662	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000159	0.000646	CbGpPWpGaD
Topiramate—CA2—Metabolism—TSHB—hypothyroidism	0.000156	0.000635	CbGpPWpGaD
Topiramate—CA12—Metabolism—SLC5A5—hypothyroidism	0.000153	0.000622	CbGpPWpGaD
Topiramate—CA1—Metabolism—TSHB—hypothyroidism	0.00015	0.000609	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3C2A—hypothyroidism	0.000145	0.00059	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000144	0.000583	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3C2A—hypothyroidism	0.000139	0.000566	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3C2A—hypothyroidism	0.000134	0.000543	CbGpPWpGaD
Topiramate—CA9—Metabolism—TSHB—hypothyroidism	0.000132	0.000535	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000131	0.000533	CbGpPWpGaD
Topiramate—CA4—Metabolism—SLC5A5—hypothyroidism	0.000122	0.000496	CbGpPWpGaD
Topiramate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000118	0.000479	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3C2A—hypothyroidism	0.000118	0.000477	CbGpPWpGaD
Topiramate—CA2—Metabolism—SLC5A5—hypothyroidism	0.000117	0.000475	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000115	0.000466	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000113	0.000459	CbGpPWpGaD
Topiramate—CA1—Metabolism—SLC5A5—hypothyroidism	0.000112	0.000456	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000103	0.00042	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—IYD—hypothyroidism	9.97e-05	0.000405	CbGpPWpGaD
Topiramate—CA9—Metabolism—SLC5A5—hypothyroidism	9.87e-05	0.000401	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	9.57e-05	0.000388	CbGpPWpGaD
Topiramate—CA5A—Metabolism—POMC—hypothyroidism	9.26e-05	0.000376	CbGpPWpGaD
Topiramate—CA6—Metabolism—POMC—hypothyroidism	9.26e-05	0.000376	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—AVP—hypothyroidism	9.04e-05	0.000367	CbGpPWpGaD
Topiramate—CA5B—Metabolism—POMC—hypothyroidism	8.65e-05	0.000351	CbGpPWpGaD
Topiramate—CA7—Metabolism—POMC—hypothyroidism	8.65e-05	0.000351	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ATP5O—hypothyroidism	8.48e-05	0.000344	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—POMC—hypothyroidism	8.45e-05	0.000343	CbGpPWpGaD
Topiramate—CA12—Metabolism—POMC—hypothyroidism	8.01e-05	0.000325	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TPO—hypothyroidism	7.97e-05	0.000324	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	7.39e-05	0.0003	CbGpPWpGaD
Topiramate—CA4—Metabolism—POMC—hypothyroidism	6.39e-05	0.000259	CbGpPWpGaD
Topiramate—CA2—Metabolism—POMC—hypothyroidism	6.13e-05	0.000249	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—IYD—hypothyroidism	6e-05	0.000243	CbGpPWpGaD
Topiramate—CA1—Metabolism—POMC—hypothyroidism	5.87e-05	0.000238	CbGpPWpGaD
Topiramate—CA9—Metabolism—POMC—hypothyroidism	5.16e-05	0.00021	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.1e-05	0.000207	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.08e-05	0.000206	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TPO—hypothyroidism	4.79e-05	0.000195	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TSHB—hypothyroidism	3.69e-05	0.00015	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	3.29e-05	0.000134	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.25e-05	0.000132	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—SLC5A5—hypothyroidism	2.76e-05	0.000112	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TSHB—hypothyroidism	2.22e-05	9.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.98e-05	8.03e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.66e-05	6.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—POMC—hypothyroidism	1.45e-05	5.87e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—POMC—hypothyroidism	8.69e-06	3.53e-05	CbGpPWpGaD
